Transcriptomic and metabonomic profiling reveal synergistic effects of quercetin and resveratrol supplementation in high fat diet fed mice

Journal of Proteome Research

Volumn 11, Issue 10, 2012, Pages 4961-4971

  Zhou, Mingmei ^a   Wang, Shidong ^a,d   Zhao, Aihua ^c,e   Wang, Ke ^d   Fan, Ziquan ^a   Yang, Hongzhou ^a   Liao, Wen ^a   Bao, Si ^a   Zhao, Linjing ^c   Zhang, Yinan ^e   Yang, Yongqing ^a   Qiu, Yunping ^b   Xie, Guoxiang ^b   Li, Houkai ^b   Jia, Wei ^a,b,e  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d National Engineering Center for Biochip at Shanghai   (China)

^e SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

fatty liver; GC MS; high fat diet; metabonomics; quercetin; resveratrol; transcriptomics

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; INSULIN; POLYPHENOL; QUERCETIN; RESVERATROL; RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; DIET SUPPLEMENTATION; FATTY ACID OXIDATION; FATTY LIVER; GAS CHROMATOGRAPHY; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; GLYCOLYSIS; HISTOLOGY; LIPID DIET; LIPID METABOLISM; LIVER LEVEL; MALE; MASS SPECTROMETRY; METABOLITE; METABOLOMICS; METABONOMICS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM; TRANSCRIPTOMICS;

ANIMALS; BLOOD GLUCOSE; CARBOHYDRATE METABOLISM; CLUSTER ANALYSIS; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FATTY LIVER; GENE EXPRESSION PROFILING; LIPID METABOLISM; LIPIDS; LIVER; MALE; METABOLOME; METABOLOMICS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE ANNOTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; QUERCETIN; STILBENES; TRANSCRIPTOME;

EID: 84867453251     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr3004826     Document Type: Article

References (58)

1. Sun, G. Y.; Xia, J.; Xu, J.; Allenbrand, B.; Simonyi, A.; Rudeen, P. K.; Sun, A. Y. Dietary supplementation of grape polyphenols to rats ameliorates chronic ethanol-induced changes in hepatic morphology without altering changes in hepatic lipids J. Nutr. 1999, 129 (10) 1814-9
2. Zhong, Z.; Connor, H. D.; Froh, M.; Lind, H.; Bunzendahl, H.; Mason, R. P.; Thurman, R. G.; Lemasters, J. J. Polyphenols from Camellia sinenesis prevent primary graft failure after transplantation of ethanol-induced fatty livers from rats Free Radicals Biol. Med. 2004, 36 (10) 1248-58
3. Agouni, A.; Lagrue-Lak-Hal, A. H.; Mostefai, H. A.; Tesse, A.; Mulder, P.; Rouet, P.; Desmoulin, F.; Heymes, C.; Martinez, M. C.; Andriantsitohaina, R. Red wine polyphenols prevent metabolic and cardiovascular alterations associated with obesity in Zucker fatty rats (Fa/Fa) PLoS One 2009, 4 (5) e5557
4. Yung, L. M.; Leung, F. P.; Wong, W. T.; Tian, X. Y.; Yung, L. H.; Chen, Z. Y.; Yao, X. Q.; Huang, Y. Tea polyphenols benefit vascular function Inflammopharmacology 2008, 16 (5) 230-4
5. Lin, J. K.; Lin-Shiau, S. Y. Mechanisms of hypolipidemic and anti-obesity effects of tea and tea polyphenols Mol. Nutr. Food Res. 2006, 50 (2) 211-7
6. Ong, K. W.; Hsu, A.; Song, L.; Huang, D.; Tan, B. K. Polyphenols-rich Vernonia amygdalina shows anti-diabetic effects in streptozotocin-induced diabetic rats J. Ethnopharmacol. 2011, 133 (2) 598-607
7. Borriello, A.; Cucciolla, V.; Della Ragione, F.; Galletti, P. Dietary polyphenols: focus on resveratrol, a promising agent in the prevention of cardiovascular diseases and control of glucose homeostasis Nutr. Metab. Cardiovasc. Dis. 2010, 20 (8) 618-25
8. Perez-Vizcaino, F.; Duarte, J.; Andriantsitohaina, R. Endothelial function and cardiovascular disease: effects of quercetin and wine polyphenols Free Radical Res. 2006, 40 (10) 1054-65
9. Hughes, D. A. Plant polyphenols: modifiers of immune function and risk of cardiovascular disease Nutrition 2005, 21 (3) 422-3
10. Patel, K. R.; Brown, V. A.; Jones, D. J.; Britton, R. G.; Hemingway, D.; Miller, A. S.; West, K. P.; Booth, T. D.; Perloff, M.; Crowell, J. A.; Brenner, D. E.; Steward, W. P.; Gescher, A. J.; Brown, K. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients Cancer Res. 2010, 70 (19) 7392-9
11. Vanamala, J.; Reddivari, L.; Radhakrishnan, S.; Tarver, C. Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways BMC Cancer 2010, 10, 238
12. Lam, T. K.; Rotunno, M.; Lubin, J. H.; Wacholder, S.; Consonni, D.; Pesatori, A. C.; Bertazzi, P. A.; Chanock, S. J.; Burdette, L.; Goldstein, A. M.; Tucker, M. A.; Caporaso, N. E.; Subar, A. F.; Landi, M. T. Dietary quercetin, quercetin-gene interaction, metabolic gene expression in lung tissue and lung cancer risk Carcinogenesis 2010, 31 (4) 634-42
13. Liao, W.; Wei, H.; Wang, X.; Qiu, Y.; Gou, X.; Zhang, X.; Zhou, M.; Wu, J.; Wu, T.; Kou, F.; Zhang, Y.; Bian, Z.; Xie, G.; Jia, W. Metabonomic Variations Associated with AOM-induced Precancerous Colorectal Lesions and Resveratrol Treatment. J. Proteome Res. 2012, not supplied.
14. Iijima, K.; Yoshizumi, M.; Hashimoto, M.; Kim, S.; Eto, M.; Ako, J.; Liang, Y. Q.; Sudoh, N.; Hosoda, K.; Nakahara, K.; Toba, K.; Ouchi, Y. Red wine polyphenols inhibit proliferation of vascular smooth muscle cells and downregulate expression of cyclin A gene Circulation 2000, 101 (7) 805-11
15. Kleemann, R.; Verschuren, L.; Morrison, M.; Zadelaar, S.; van Erk, M. J.; Wielinga, P. Y.; Kooistra, T. Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models Atherosclerosis 2011, 218 (1) 44-52
16. Wein, S.; Behm, N.; Petersen, R. K.; Kristiansen, K.; Wolffram, S. Quercetin enhances adiponectin secretion by a PPAR-gamma independent mechanism Eur. J. Pharm. Sci. 2010, 41 (1) 16-22
17. Juzwiak, S.; Wojcicki, J.; Mokrzycki, K.; Marchlewicz, M.; Bialecka, M.; Wenda-Rozewicka, L.; Gawronska-Szklarz, B.; Drozdzik, M. Effect of quercetin on experimental hyperlipidemia and atherosclerosis in rabbits Pharmacol. Rep. 2005, 57 (5) 604-9
18. Gnoni, G. V.; Paglialonga, G.; Siculella, L. Quercetin inhibits fatty acid and triacylglycerol synthesis in rat-liver cells Eur. J. Clin. Invest. 2009, 39 (9) 761-8
19. Pace-Asciak, C. R.; Hahn, S.; Diamandis, E. P.; Soleas, G.; Goldberg, D. M. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease Clin. Chim. Acta 1995, 235 (2) 207-19
20. Zern, T. L.; Fernandez, M. L. Cardioprotective effects of dietary polyphenols J. Nutr. 2005, 135 (10) 2291-4
21. Jang, M.; Cai, L.; Udeani, G. O.; Slowing, K. V.; Thomas, C. F.; Beecher, C. W.; Fong, H. H.; Farnsworth, N. R.; Kinghorn, A. D.; Mehta, R. G.; Moon, R. C.; Pezzuto, J. M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 1997, 275 (5297) 218-20
22. Timmers, S.; Konings, E.; Bilet, L.; Houtkooper, R. H.; van de Weijer, T.; Goossens, G. H.; Hoeks, J.; van der Krieken, S.; Ryu, D.; Kersten, S.; Moonen-Kornips, E.; Hesselink, M. K.; Kunz, I.; Schrauwen-Hinderling, V. B.; Blaak, E. E.; Auwerx, J.; Schrauwen, P. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans Cell Metab. 2011, 14 (5) 612-22
23. Kleinedler, J. J.; Foley, J. D.; Alexander, J. S.; Roerig, S. C.; Hebert, V. Y.; Dugas, T. R. Synergistic effect of resveratrol and quercetin released from drug-eluting polymer coatings for endovascular devices J. Biomed. Mater. Res., B: Appl. Biomater. 2011, 99 (2) 266-75
24. Zamin, L. L.; Filippi-Chiela, E. C.; Dillenburg-Pilla, P.; Horn, F.; Salbego, C.; Lenz, G. Resveratrol and quercetin cooperate to induce senescence-like growth arrest in C6 rat glioma cells Cancer Sci. 2009, 100 (9) 1655-62
25. Yang, J. Y.; Della-Fera, M. A.; Rayalam, S.; Ambati, S.; Hartzell, D. L.; Park, H. J.; Baile, C. A. Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin Life Sci. 2008, 82 (19-20) 1032-9
26. Griffin, J. L.; Bonney, S. A.; Mann, C.; Hebbachi, A. M.; Gibbons, G. F.; Nicholson, J. K.; Shoulders, C. C.; Scott, J. An integrated reverse functional genomic and metabolic approach to understanding orotic acid-induced fatty liver Physiol. Genomics 2004, 17 (2) 140-9
27. Coen, M.; Ruepp, S. U.; Lindon, J. C.; Nicholson, J. K.; Pognan, F.; Lenz, E. M.; Wilson, I. D. Integrated application of transcriptomics and metabonomics yields new insight into the toxicity due to paracetamol in the mouse J. Pharm. Biomed. Anal. 2004, 35 (1) 93-105
28. Borgan, E.; Sitter, B.; Lingjaerde, O. C.; Johnsen, H.; Lundgren, S.; Bathen, T. F.; Sorlie, T.; Borresen-Dale, A. L.; Gribbestad, I. S. Merging transcriptomics and metabolomics - advances in breast cancer profiling BMC Cancer 2010, 10, 628
29. Nam, H.; Chung, B. C.; Kim, Y.; Lee, K.; Lee, D. Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification Bioinformatics 2009, 25 (23) 3151-7
30. Jennen, D.; Ruiz-Aracama, A.; Magkoufopoulou, C.; Peijnenburg, A.; Lommen, A.; van Delft, J.; Kleinjans, J. Integrating transcriptomics and metabonomics to unravel modes-of-action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in HepG2 cells BMC Syst. Biol. 2011, 5, 139
31. Dutta, T.; Chai, H. S.; Ward, L. E.; Ghosh, A.; Persson, X. M.; Ford, G. C.; Kudva, Y. C.; Sun, Z.; Asmann, Y. W.; Kocher, J. P.; Nair, K. S. Concordance of changes in metabolic pathways based on plasma metabolomics and skeletal muscle transcriptomics in type 1 diabetes Diabetes 2012, 61 (5) 1004-16
32. Connor, S. C.; Hansen, M. K.; Corner, A.; Smith, R. F.; Ryan, T. E. Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes Mol. Biosyst. 2010, 6 (5) 909-21
33. Hirai, M. Y.; Yano, M.; Goodenowe, D. B.; Kanaya, S.; Kimura, T.; Awazuhara, M.; Arita, M.; Fujiwara, T.; Saito, K. Integration of transcriptomics and metabolomics for understanding of global responses to nutritional stresses in Arabidopsis thaliana Proc. Natl. Acad. Sci. U. S. A. 2004, 101 (27) 10205-10
34. Li, H.; Xie, Z.; Lin, J.; Song, H.; Wang, Q.; Wang, K.; Su, M.; Qiu, Y.; Zhao, T.; Song, K.; Wang, X.; Zhou, M.; Liu, P.; Zhao, G.; Zhang, Q.; Jia, W. Transcriptomic and metabonomic profiling of obesity-prone and obesity-resistant rats under high fat diet J. Proteome Res. 2008, 7 (11) 4775-83
35. Folch, J.; Lees, M.; Sloane Stanley, G. H. A simple method for the isolation and purification of total lipides from animal tissues J. Biol. Chem. 1957, 226 (1) 497-509
36. Pan, L.; Qiu, Y.; Chen, T.; Lin, J.; Chi, Y.; Su, M.; Zhao, A.; Jia, W. An optimized procedure for metabonomic analysis of rat liver tissue using gas chromatography/time-of-flight mass spectrometry J. Pharm. Biomed. Anal. 2010, 52 (4) 589-96
37. Cheadle, C.; Vawter, M. P.; Freed, W. J.; Becker, K. G. Analysis of microarray data using Z score transformation J. Mol. Diagn 2003, 5 (2) 73-81
38. Cheadle, C.; Cho-Chung, Y. S.; Becker, K. G.; Vawter, M. P. Application of z-score transformation to Affymetrix data Appl. Bioinf. 2003, 2 (4) 209-17
39. Kim, S. Y.; Volsky, D. J. PAGE: parametric analysis of gene set enrichment BMC Bioinf. 2005, 6, 144
40. De, S.; Zhang, Y.; Garner, J. R.; Wang, S. A.; Becker, K. G. Disease and phenotype gene set analysis of disease-based gene expression in mouse and human Physiol. Genomics 2010, 42A (2) 162-7
41. Bult, C. J.; Eppig, J. T.; Kadin, J. A.; Richardson, J. E.; Blake, J. A. The Mouse Genome Database (MGD): mouse biology and model systems Nucleic Acids Res. 2008, 36 (Database issue) D724-8
42. Carson, F. L. Histotechnology: A Self-Instructional Text, 2 nd ed.; American Society for Clinical Pathology Press: Chicago, 1997.
43. Gnoni, G. V.; Paglialonga, G. Resveratrol inhibits fatty acid and triacylglycerol synthesis in rat hepatocytes Eur. J. Clin. Invest. 2009, 39 (3) 211-8
44. Tian, J.; Dang, H. N.; Yong, J.; Chui, W. S.; Dizon, M. P.; Yaw, C. K.; Kaufman, D. L. Oral treatment with gamma-aminobutyric acid improves glucose tolerance and insulin sensitivity by inhibiting inflammation in high fat diet-fed mice PLoS One 2011, 6 (9) e25338
45. Niu, Y. C.; Feng, R. N.; Hou, Y.; Li, K.; Kang, Z.; Wang, J.; Sun, C. H.; Li, Y. Histidine and arginine are associated with inflammation and oxidative stress in obese women Br. J. Nutr. 2011, 1-5
46. Mong, M. C.; Chao, C. Y.; Yin, M. C. Histidine and carnosine alleviated hepatic steatosis in mice consumed high saturated fat diet Eur. J. Pharmacol. 2011, 653 (1-3) 82-8
47. Kasaoka, S.; Tsuboyama-Kasaoka, N.; Kawahara, Y.; Inoue, S.; Tsuji, M.; Ezaki, O.; Kato, H.; Tsuchiya, T.; Okuda, H.; Nakajima, S. Histidine supplementation suppresses food intake and fat accumulation in rats Nutrition 2004, 20 (11-12) 991-6
48. Gupte, A. A.; Bomhoff, G. L.; Swerdlow, R. H.; Geiger, P. C. Heat treatment improves glucose tolerance and prevents skeletal muscle insulin resistance in rats fed a high-fat diet Diabetes 2009, 58 (3) 567-78
49. Kannappan, S.; Anuradha, C. V. Insulin sensitizing actions of fenugreek seed polyphenols, quercetin & metformin in a rat model Indian J. Med. Res. 2009, 129 (4) 401-8
50. Marchal, J.; Blanc, S.; Epelbaum, J.; Aujard, F.; Pifferi, F. Effects of Chronic Calorie Restriction or Dietary Resveratrol Supplementation on Insulin Sensitivity Markers in a Primate, Microcebus murinus PLoS One 2012, 7 (3) e34289
51. Brasnyo, P.; Molnar, G. A.; Mohas, M.; Marko, L.; Laczy, B.; Cseh, J.; Mikolas, E.; Szijarto, I. A.; Merei, A.; Halmai, R.; Meszaros, L. G.; Sumegi, B.; Wittmann, I. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients Br. J. Nutr. 2011, 106 (3) 383-9
52. Iqbal, M. A.; Bamezai, R. N. Resveratrol inhibits cancer cell metabolism by down regulating pyruvate kinase M2 via inhibition of mammalian target of rapamycin PLoS One 2012, 7 (5) e36764
53. Kueck, A.; Opipari, A. W., Jr.; Griffith, K. A.; Tan, L.; Choi, M.; Huang, J.; Wahl, H.; Liu, J. R. Resveratrol inhibits glucose metabolism in human ovarian cancer cells Gynecol. Oncol. 2007, 107 (3) 450-7
54. Gasparin, F. R.; Spitzner, F. L.; Ishii-Iwamoto, E. L.; Bracht, A.; Constantin, J. Actions of quercetin on gluconeogenesis and glycolysis in rat liver Xenobiotica 2003, 33 (9) 903-11
55. Pan, P. H.; Lin, S. Y.; Ou, Y. C.; Chen, W. Y.; Chuang, Y. H.; Yen, Y. J.; Liao, S. L.; Raung, S. L.; Chen, C. J. Stearic acid attenuates cholestasis-induced liver injury Biochem. Biophys. Res. Commun. 2010, 391 (3) 1537-42
56. Park, J. M.; Kim, T. H.; Bae, J. S.; Kim, M. Y.; Kim, K. S.; Ahn, Y. H. Role of resveratrol in FOXO1-mediated gluconeogenic gene expression in the liver Biochem. Biophys. Res. Commun. 2010, 403 (3-4) 329-34
57. Gonzalez-Mujica, F.; Motta, N.; Estrada, O.; Perdomo, E.; Mendez, J.; Hasegawa, M. Inhibition of hepatic neoglucogenesis and glucose-6-phosphatase by quercetin 3-O-alpha(2?-galloyl)rhamnoside isolated from Bauhinia megalandra leaves Phytother. Res. 2005, 19 (7) 624-7
58. Nicholson, J. K.; Connelly, J.; Lindon, J. C.; Holmes, E. Metabonomics: a platform for studying drug toxicity and gene function Nat. Rev. Drug Discovery 2002, 1 (2) 153-61